drugset / Trial / NCT07396844
The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This is a single dose, randomized, open-label, two-way crossover study to investigate the food-effect bioavailability of the fixed-dose combination of Gemigliptin/Dapagliflozin/Metformin 50/10/1000 mg in healthy volunteers under fasting and fed conditions.
Timeline
- Start
- 2026-06-11
- Primary completion
- 2026-06-26
- Completion
- 2026-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 10 mg | — |
| Subject | Gemigliptin | Small molecule | 50 mg | — |
| Subject | Metformin | Small molecule | 1000 mg | — |
Indications
No indication recorded.